FDG Imaging Should Be Considered the Preferred Technique for Accurate Assessment of Myocardial Viability: for

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2005 May 25

PMID 15912400

Citations 1

Authors

Jeroen J Bax

Affiliations

Soon will be listed here.

Citing Articles

Individual differences in the effectiveness of intracoronary bone marrow cell transplantation assessed by gated sestamibi SPECT/FDG PET imaging.

Kaminek M, Meluzin J, Panovsky R, Janousek S, Mayer J, Prasek J J Nucl Cardiol. 2008; 15(3):392-9.

PMID: 18513646 DOI: 10.1016/j.nuclcard.2008.02.016.

References

Bax J, Poldermans D, Elhendy A, Boersma E, Rahimtoola S . Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol. 2001; 26(2):147-86. DOI: 10.1067/mcd.2001.109973. View

Haas F, Augustin N, Holper K, Wottke M, Haehnel C, Nekolla S . Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol. 2000; 36(6):1927-34. DOI: 10.1016/s0735-1097(00)00968-2. View

Bax J, Wijns W . Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?. J Nucl Med. 1999; 40(11):1893-5. View

Matsunari I, Boning G, Ziegler S, Nekolla S, Stollfuss J, Kosa I . Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose. J Am Coll Cardiol. 1998; 32(4):927-35. DOI: 10.1016/s0735-1097(98)00340-4. View

Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M . Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986; 314(14):884-8. DOI: 10.1056/NEJM198604033141405. View

Di Carli M, Asgarzadie F, Schelbert H, Brunken R, Laks H, Phelps M . Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995; 92(12):3436-44. DOI: 10.1161/01.cir.92.12.3436. View

Pagano D, Townend J, Parums D, Bonser R, Camici P . Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart. 2000; 83(4):456-61. PMC: 1729369. DOI: 10.1136/heart.83.4.456. View

Di Carli M, Davidson M, Little R, Khanna S, Mody F, Brunken R . Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994; 73(8):527-33. DOI: 10.1016/0002-9149(94)90327-1. View

Bax J, Patton J, Poldermans D, Elhendy A, Sandler M . 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications. Semin Nucl Med. 2000; 30(4):281-98. DOI: 10.1053/snuc.2000.9543. View

10.

Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M . Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 1989; 64(14):860-5. DOI: 10.1016/0002-9149(89)90832-1. View

11.

Beanlands R, deKemp R, Smith S, Johansen H, Ruddy T . F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function. Am J Cardiol. 1997; 79(8):1092-5. DOI: 10.1016/s0002-9149(97)00054-4. View

12.

Marwick T, Nemec J, Lafont A, Salcedo E, MACINTYRE W . Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol. 1992; 69(9):854-9. DOI: 10.1016/0002-9149(92)90782-t. View

13.

Gheorghiade M, Bonow R . Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998; 97(3):282-9. DOI: 10.1161/01.cir.97.3.282. View

14.

Bax J, van der Wall E, Harbinson M . Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart. 2004; 90 Suppl 5:v26-33. PMC: 1876321. DOI: 10.1136/hrt.2002.007575. View